Serum Institute of India led a Phase 2 trial demonstrating the therapeutic effect of Dengue-mAb.
1 report, 1 independent
Updated Aug 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Serum Institute of India led a Phase 2 trial demonstrating the therapeutic effect of Dengue-mAb.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Serum Institute of India
Indian biotechnological company, vaccine manufacturer
Nothing else this week.